GPC1 and familial pancreatic carcinoma: The abundance of glypican-1 positively correlates with disease severity in patients, whether they have received surgical treatment or not, suggesting that glypican is a surgery-independent, inherent diagnostic biomarker of pancreatic cancer [240].